Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B

Hepatobiliary and Pancreatic Diseases International

Volumn 12, Issue 4, 2013, Pages 394-399

  Zhang, Wen Jin ^a   Peng, Chuan Hui ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chronic; Hepatitis B; Liver; Programmed death 1 receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; CHEMOKINE RECEPTOR CCR6; CORE PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POL PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; VIRUS ENVELOPE PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL AGGREGATION; CLINICAL ARTICLE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; PROTEIN EXPRESSION; VIRAL CLEARANCE; VIRUS INACTIVATION;

ANTIGENS, CD274; CD8-POSITIVE T-LYMPHOCYTES; CELL AGGREGATION; CELL MOVEMENT; CYTOPROTECTION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LYMPHOCYTE COUNT; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, CCR6;

EID: 84886502709     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(13)60061-2     Document Type: Article

References (26)

1. Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008;205: 2111-2124.
2. Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008;45:963-970.
3. Evans A, Riva A, Cooksley H, Phillips S, Puranik S, Nathwani A, et al. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. Hepatology 2008;48:759-769.
4. Chen L, Zhang Z, Chen W, Zhang Z, Li Y, Shi M, et al. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 2007;178:6634-6641.
5. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, et al. Characterization of hepatitis B virus (HBV) -specific T-cell dysfunction in chronic HBV infection. J Virol 2007;81:4215-4225.
6. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 2008;134:1938-1949.
7. Kassel R, Cruise MW, Iezzoni JC, Taylor NA, Pruett TL, Hahn YS. Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology 2009;50:1625-1637.
8. Zhang WJ, Xie HY, Duan X, Wan YL, Peng CH, Shi SH, et al. Study of human B7 homolog 1 expression in patients with hepatitis B virus infection. World J Gastroenterol 2012;18: 3681-3695.
9. Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003;198:39-50.
10. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000;192:1027-1034.
11. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999;5:1365-1369.
12. Eppihimer MJ, Gunn J, Freeman GJ, Greenfeld EA, Chernova T, Erickson J, et al. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 2002;9:133-145.
13. Müllbacher A, Flynn K. Aspects of cytotoxic T cell memory. Immunol Rev 1996;150:113-127.
14. Flynn K, Müllbacher A. The generation of memory antigen-specific cytotoxic T cell responses by CD28/CD80 interactions in the absence of antigen. Eur J Immunol 1997;27:456-462.
15. Karrar A, Broomé U, Uzunel M, Qureshi AR, Sumitran-Holgersson S. Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction. Gut 2007;56:243-252.
16. Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997;272:14893-14898.
17. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999;162:186-194.
18. Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. Regulation of dendritic cell traffcking: a process that involves the participation of selective chemokines. J Leukoc Biol 1999;66: 252-262.
19. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000;191:1269-1280.
20. Wuensch SA, Pierce RH, Crispe IN. Local intrahepatic T CD8 cell activation by a non-self-antigen results in full functional differentiation. J Immunol 2006;177:1689-1697.
21. Mehal WZ, Juedes AE, Crispe IN. Selective retention of + TJ activated CD8 cells by the normal liver. Immunol 1999;163:3202-3210.
22. John B, Crispe IN. LR-4 regulates CD8 cell trapping in the liver. J Immunol 2005;175:1643-1650.
23. John B, Crispe IN. Passive and active mechanisms trap + T activated CD8 cells in the liver. Immunol 2004;172:5222-5229.
24. Armah GE, Breiman RF, Tapia MD, Dallas MJ, Neuzil KM, Binka FN, et al. Immunogenicity of the pentavalent rotavirus vaccine in African infants. Vaccine 2012;30:A86-A93.
25. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12:252-264.
26. Kline J, Gajewski TF. Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer. Curr Opin Investig Drugs 2010;11:1354-1359.